Can magnesium supplementation reduce seizures in people with epilepsy? A hypothesis

Epilepsy Research

Volumn 100, Issue 1-2, 2012, Pages 152-156

  Yuen, Alan W C ^a,b   Sander, Josemir W ^a,b,c  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b EPILEPSY SOCIETY   (United Kingdom)

^c STICHTING EPILEPSIE INSTELLINGEN NEDERLAND SEIN   (Netherlands)

Author keywords

Epilepsy; Magnesium deficiency; NMDA; Seizure thresholds

Indexed keywords

CORTICOTROPIN; MAGNESIUM SULFATE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR;

ARTICLE; BRAIN DEPTH STIMULATION; BRAIN SLICE; CONCENTRATION (PARAMETERS); DIET SUPPLEMENTATION; DISEASE ACTIVITY; DISEASE ASSOCIATION; DNA TRANSCRIPTION; EPILEPTIC DISCHARGE; GLYCOLYSIS; HUMAN; INFANTILE SPASM; MAGNESIUM DEFICIENCY; NONHUMAN; OXIDATIVE PHOSPHORYLATION; PRIORITY JOURNAL; PROTEIN SYNTHESIS INHIBITION; SEIZURE; THERAPY EFFECT;

ANIMALS; DIETARY SUPPLEMENTS; DISEASE MODELS, ANIMAL; EPILEPSY; HUMANS; MAGNESIUM; MAGNESIUM DEFICIENCY;

EID: 84861528116     PISSN: 09201211     EISSN: 18726844     Source Type: Journal    
DOI: 10.1016/j.eplepsyres.2012.02.004     Document Type: Article

References (49)

1. Alaimo K., McDowell M.A., Briefel R.R., Bischof A.M., Caughman C.R., Loria C.M., Johnson C.L. Dietary intake of vitamins, minerals, and fiber of persons ages 2 months and over in the United States: Third National Health and Nutrition Examination Survey, Phase 1, 1988-91. Adv. Data 1994, 1-28.
2. Anderson W.W., Lewis D.V., Swartzwelder H.S., Wilson W.A. Magnesium-free medium activates seizure-like events in the rat hippocampal slice. Brain Res. 1986, 398:215-219.
3. Canelas H.M., De Assis L.M., De Jorge F.B. Disorders of magnesium metabolism in epilepsy. J. Neurol. Neurosurg. Psychiatry 1965, 28:378-381.
4. Chien P.F., Khan K.S., Arnott N. Magnesium sulphate in the treatment of eclampsia and pre-eclampsia: an overview of the evidence from randomised trials. Br. J. Obstet. Gynaecol. 1996, 103:1085-1091.
5. Coan E.J., Collingridge G.L. Magnesium ions block an N-methyl-d-aspartate receptor-mediated component of synaptic transmission in rat hippocampus. Neurosci. Lett. 1985, 53:21-26.
6. Cotton D.B., Hallak M., Janusz C., Irtenkauf S.M., Berman R.F. Central anticonvulsant effects of magnesium sulfate on N-methyl-d-aspartate-induced seizures. Am. J. Obstet. Gynecol. 1993, 168:974-978.
7. Curiel-Garcia J.A., Rodriguez-Moran M., Guerrero-Romero F. Hypomagnesemia and mortality in patients with type 2 diabetes. Magnesium Res. 2008, 21:163-166.
8. Decollogne S., Tomas A., Lecerf C., Adamowicz E., Seman M. NMDA receptor complex blockade by oral administration of magnesium: comparison with MK-801. Pharmacol. Biochem. Behav. 1997, 58:261-268.
9. Fagan C., Phelan D. Severe convulsant hypomagnesaemia and short bowel syndrome. Anaesth. Intens. Care 2001, 29:281-283.
10. Fawcett W.J., Haxby E.J., Male D.A. Magnesium: physiology and pharmacology. Br. J. Anaesth. 1999, 83:302-320.
11. Guerrera M.P., Volpe S.L., Mao J.J. Therapeutic uses of magnesium. Am. Fam. Physician 2009, 80:157-162.
12. Gupta S.K., Manhas A.S., Gupta V.K., Bhatt R. Serum magnesium levels in idiopathic epilepsy. J. Assoc. Physicians India 1994, 42:456-457.
13. Isaev D., Ivanchick G., Khmyz V., Isaeva E., Savrasova A., Krishtal O., Holmes G.L., Maximyuk O. Surface charge impact in low-magnesium model of seizure in rat hippocampus. J. Neurophysiol. 2012, 107(1):417-423.
14. Iseri L.T., Allen B.J., Brodsky M.A. Magnesium therapy of cardiac arrhythmias in critical-care medicine. Magnesium 1989, 8:299-306.
15. Jee S.H., Miller E.R., Guallar E., Singh V.K., Appel L.J., Klag M.J. The effect of magnesium supplementation on blood pressure: a meta-analysis of randomized clinical trials. Am. J. Hypertens. 2002, 15:691-696.
16. Jung K.I., Ock S.M., Chung J.H., Song C.H. Associations of serum Ca and Mg levels with mental health in adult women without psychiatric disorders. Biol. Trace Elem. Res. 2010, 133(2):153-161.
17. Kwan P., Brodie M.J. Early identification of refractory epilepsy. N. Engl. J. Med. 2000, 342:314-319.
18. Larsson S.C., Virtanen M.J., Mars M., Mannisto S., Pietinen P., Albanes D., Virtamo J. Magnesium, calcium, potassium, and sodium intakes and risk of stroke in male smokers. Arch. Intern. Med. 2008, 168:459-465.
19. Leaver D.D., Parkinson G.B., Schneider K.M. Neurological consequences of magnesium deficiency: correlations with epilepsy. Clin. Exp. Pharmacol. Physiol. 1987, 14:361-370.
20. Liao F., Folsom A.R., Brancati F.L. Is low magnesium concentration a risk factor for coronary heart disease? The Atherosclerosis Risk in Communities (ARIC) Study. Am. Heart J. 1998, 136:480-490.
21. Lichtenstein A.H., Appel L.J., Brands M., Carnethon M., Daniels S., Franch H.A., Franklin B., Kris-Etherton P., Harris W.S., Howard B., Karanja N., Lefevre M., Rudel L., Sacks F., Van H.L., Winston M., Wylie-Rosett J. Diet and lifestyle recommendations revision 2006: a scientific statement from the American Heart Association Nutrition Committee. Circulation 2006, 114:82-96.
22. Lopez-Ridaura R., Willett W.C., Rimm E.B., Liu S., Stampfer M.J., Manson J.E., Hu F.B. Magnesium intake and risk of type 2 diabetes in men and women. Diabetes Care 2004, 27:134-140.
23. Mahabir S., Wei Q., Barrera S.L., Dong Y.Q., Etzel C.J., Spitz M.R., Forman M.R. Dietary magnesium and DNA repair capacity as risk factors for lung cancer. Carcinogenesis 2008, 29:949-956.
24. Mocci F., Canalis P., Tomasi P.A., Casu F., Pettinato S. The effect of noise on serum and urinary magnesium and catecholamines in humans. Occup. Med. (Lond.) 2001, 51:56-61.
25. Mohammed S., Goodacre S. Intravenous and nebulised magnesium sulphate for acute asthma: systematic review and meta-analysis. Emerg. Med. J. 2007, 24:823-830.
26. Nechifor M. Magnesium in major depression. Magnesium Res. 2009, 22:163S-166S.
27. Odette O. Grass tetany in a herd of beef cows. Can. Vet. J. 2005, 46:732-734.
28. Oladipo O.O., Ajala M.O., Okubadejo N., Danesi M.A., Afonja O.A. Plasma magnesium in adult Nigerian patients with epilepsy. Niger Postgrad. Med. J. 2003, 10:234-237.
29. Pandey M., Gupta A., Baduni N., Vijfdar H., Sinha S., Jain A. Refractory status epilepticus-magnesium as rescue therapy. Anaesth. Intensive Care 2010, 38:962.
30. Pati S., Alexopoulos A.V. Pharmacoresistant epilepsy: from pathogenesis to current and emerging therapies. Cleve Clin. J. Med. 2010, 77:457-467.
31. Prebble J.J. Primary infantile hypomagnesaemia: report of two cases. J. Paediatr. Child Health 1995, 31:54-56.
32. 2+ in intact immature brain structures. Eur. J. Neurosci. 2002, 16:850-860.
33. Rude R.K. Magnesium deficiency: a cause of heterogeneous disease in humans. J. Bone Miner. Res. 1998, 13:749-758.
34. Ryder K.M., Shorr R.I., Bush A.J., Kritchevsky S.B., Harris T., Stone K., Cauley J., Tylavsky F.A. Magnesium intake from food and supplements is associated with bone mineral density in healthy older white subjects. J. Am. Geriatr. Soc. 2005, 53:1875-1880.
35. Rylander R., Megevand Y., Lasserre B., Amstutz W., Granbom S. Moderate alcohol consumption and urinary excretion of magnesium and calcium. Scand J. Clin. Lab. Invest. 2001, 61:401-405.
36. Safar M.M., Abdallah D.M., Arafa N.M., Abdel-Aziz M.T. Magnesium supplementation enhances the anticonvulsant potential of valproate in pentylenetetrazol-treated rats. Brain Res. 2010, 1334:58-64.
37. Sander J.W. Some aspects of prognosis in the epilepsies: a review. Epilepsia 1993, 34:1007-1016.
38. Sinert R., Zehtabchi S., Desai S., Peacock P., Altura B.T., Altura B.M. Serum ionized magnesium and calcium levels in adult patients with seizures. Scand J. Clin. Lab. Invest. 2007, 67:317-326.
39. Sood A.K., Handa R., Malhotra R.C., Gupta B.S. Serum, CSF, RBC & urinary levels of magnesium & calcium in idiopathic generalised tonic clonic seizures. Indian J. Med. Res. 1993, 98:152-154.
40. Spasov A.A., Iezhitsa I.N., Kharitonova M.V., Kravchenko M.S. Effect of magnesium chloride and magnesium l-aspartate on seizure threshold in rats under conditions of dietary magnesium deficiency. Bull. Exp. Biol. Med. 2007, 144:214-216.
41. Tancredi V., Avoli M., Hwa G.G. Low-magnesium epilepsy in rat hippocampal slices: inhibitory postsynaptic potentials in the CA1 subfield. Neurosci. Lett. 1988, 89:293-298.
42. Thomas D. The mineral depletion of foods available to us as a nation (1940-2002)-a review of the 6th Edition of McCance and Widdowson. Nutr. Health 2007, 19:21-55.
43. Tsuji H., Venditti F.J., Evans J.C., Larson M.G., Levy D. The associations of levels of serum potassium and magnesium with ventricular premature complexes (the Framingham Heart Study). Am. J. Cardiol. 1994, 74:232-235.
44. Unachak K., Louthrenoo O., Katanyuwong K. Primary hypomagnesemia in Thai infants: a case report with 7 years follow-up and review of literature. J. Med. Assoc. Thai. 2002, 85:1226-1231.
45. Visser N.A., Braun K.P., Leijten F.S., van N.O., Wokke J.H., van den Bergh W.M. Magnesium treatment for patients with refractory status epilepticus due to POLG1-mutations. J. Neurol. 2011, 258:218-222.
46. Visudhiphan P., Visudtibhan A., Chiemchanya S., Khongkhatithum C. Neonatal seizures and familial hypomagnesemia with secondary hypocalcemia. Pediatr. Neurol. 2005, 33:202-205.
47. Walker A.F., Marakis G., Christie S., Byng M. Mg citrate found more bioavailable than other Mg preparations in a randomised, double-blind study. Magnesium Res. 2003, 16:183-191.
48. Weisleder P., Tobin J.A., Kerrigan J.F., Bodensteiner J.B. Hypomagnesemic seizures: case report and presumed pathophysiology. J. Child Neurol. 2002, 17:59-61.
49. Zou L.P., Wang X., Dong C.H., Chen C.H., Zhao W., Zhao R.Y. Three-week combination treatment with ACTH+magnesium sulfate versus ACTH monotherapy for infantile spasms: a 24-week, randomized, open-label, follow-up study in China. Clin. Ther. 2010, 32:692-700.